A4 Infection

Topic

Infection occurs when a pathogen - bacteria, virus, fungus or parasite - invades the body and reproduces following its own life cycle. At the population level, its ability to spread depends on the average number of new organisms that each infected individual infects during their infectious period. If this number is greater than one, the infection spreads; if it is less than one, it tends to disappear.

This number also depends on the proportion of individuals that remain susceptible. Vaccination reduces this fraction and, when immunization reaches a sufficient level, each infected person generates on average less than one new infection. Transmission then decreases even if the pathogen continues to circulate, providing indirect protection to unvaccinated people through herd immunity.

Within an infected organism, the pathogen follows a different dynamic. It infects certain target cells, reproduces in them and generates new particles capable of infecting other cells, while the host's defenses try to eliminate them. In hepatitis B the target cells are hepatocytes, while the human immunodeficiency virus infects certain lymphocytes. If each infected cell generates enough particles capable of initiating new infections before being eliminated, the amount of pathogen increases and can progressively destroy the affected cell population. Antivirals seek to reduce this capacity, reducing the production of new particles or making it difficult for them to infect new cells.

In bacterial infections, neutrophils constitute a fundamental defense. When there are few bacteria, their elimination capacity increases approximately with the bacterial load. However, as the number of bacteria grows excessively, the available neutrophils can become saturated and their rate of destruction stops increasing proportionally. If the number of circulating neutrophils is very low, even a bacterial load that would normally be controlled can progress to generalized infection.

Antibiotics help tip this balance in favor of the body, but their effectiveness depends on different relationships between concentration and effect. For some, what matters is how long its concentration remains above the minimum concentration needed to inhibit bacteria. In others it is essential to achieve a high peak concentration, while for others the total exposure accumulated during treatment is important. Adapting the dose and administration interval to these characteristics makes it possible to increase the bactericidal effect and reduce the probability of the emergence of resistance.

When defenses and treatment do not contain the infection in a timely manner, an uncontrolled systemic inflammatory response can develop: sepsis. In it, inflammatory mediators stop acting only as defensive mechanisms and begin to contribute to the damage of the body itself. They can alter the internal surface of the vessels, affect coagulation and simultaneously compromise the functioning of various organs.

The severity of this dysfunction can be evaluated by considering together six systems: respiratory, coagulation, liver, cardiovascular, central nervous system and kidney. The combination of these alterations allows us to quantify the organic compromise associated with sepsis. When a persistent drop in blood pressure also appears along with an increase in lactic acid in the blood, the condition can progress to septic shock, the most serious form of this response.

Taken together, an infection can be analyzed at several connected levels. In the population, transmission depends on the number of susceptible people and can be limited by vaccination. Within the body, the result depends on the balance between reproduction of the pathogen and the ability of the defenses to eliminate it. Neutrophils play a central role against bacteria, while antivirals and antibiotics directly interfere with the cycle of the infectious agent. If these mechanisms are insufficient, the inflammatory response itself can become a source of damage and lead to sepsis and multiple organ dysfunction. Prevention, timely antimicrobial treatment, and monitoring of the systemic response seek to interrupt this progression before the cycle of infection and damage becomes out of control.

ID:2266